IMPAKT 2016: Sponsor Profiles
Agendia is a leading molecular diagnostic company that develops and markets FFPE-based genomic testing which help support physicians with their complex treatment decisions.
The Agendia Breast Cancer Test Suite includes MammaPrint®, the 70-gene breast cancer recurrence assay, the first FDA-cleared and only breast cancer recurrence assay backed by peer-reviewed, prospective outcome data, BluePrint®, the 80-gene molecular subtyping assay that identifies Luminal-type, Basal-type and HER2-type breast cancer molecular subtypes and TargetPrint®, an ER/PR/HER2 expression assay. For more information, please visit the company website.
La Roche Ltd
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and neuroscience.
Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche’s personalised healthcare strategy aims at providing medicines and diagnostics that enable tangible improvements in the health, quality of life and survival of patients. For more information, please visit the company website
Pfizer Oncology is committed to the research and discovery of breakthrough treatment options, including small molecules, biologics and immunotherapies, to improve the outlook for cancer patients worldwide. For more information please visit the company website
Booth number: A1+A2
MSD Merck Sharp and Dohme AG
Today's MSD is a global health care leader working to help the world be well. MSD is a tradename of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. Through our prescription medicines, vaccines, biologic therapies and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to health care through far-reaching policies, programs and partnerships. For more information, please visit the company website
Booth number: D1
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide. We seek to deliver truly innovative and life-changing drugs for our patients through the discovery, development, and commercialization of products for cancer and other severe, immune, inflammatory conditions. Celgene employs more than 5,300 employees worldwide. For more information, please visit the company website
Booth number: A3
For more than 50 years, Lilly has been dedicated to delivering life-changing medicines and support to people living with cancer and those who care for them. Lilly is determined to build on this heritage and continue making life better for all those affected by cancer around the world. To learn more about Lilly’s commitment to people with cancer, please visit the company website